Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation

Table 1 Diagnostic chart of patients with HCC

Diagnoses	n	Age (yr, mean ± SD)
No liver disease	10	61 ± 12.2
Fibrosis	3	66.7 ± 0.6
Alcohol induced cirrhosis	23	60 ± 8.3
Hepatitis (C) cirrhosis	22	55.9 ± 9.9
Hepatitis (B) cirrhosis	18	55 ± 14.1
Others1	8	56 ± 16.9
Total	84	59 ± 11.4

¹ Haemochromatosis 2, Caroli-syndrome 1, primary biliary cirrhosis 1, primary sclerosing cholangitis 1, hepatitis C 1, acute liver faliure 1, cryptogene cirrhosis 1. The majority of patients had liver cirrhosis secondary to viral hepatitis and alcohol-related liver disease.

Table 2 Cirrhosis scoring of study patients according to Child-Pugh Score

Child-Pugh Score	n	Age	Gender
		(yr, mean ± SD)	Male	Female
A	28	56 ± 13.2	26	2
B	29	57 ± 9.7	25	4
C	17	56 ± 9.1	15	2
Total	74	56.3 ± 11.3	66	8

HCC was classified at hospital admission

Table 3 Staging of the patients according to UICC

UICC stage	n	No cirrhosis	Cirrhosis	Age (yr, mean ± SD)
I	5	1	4	52 ± 11.7
II	13	1	12	60 ± 13.5
III	11	3	8	60.8 ± 8.0
IV	55	5	50	58 ± 11.6
Total	84	10	74	59 ± 11.4

Table 4 Treatment modalities of patients with HCC

Treatment	n	No cirrhosis	Cirrhosis
No treatment	10	3	7
TACE, not listed for OLT	32	6	41
TACE, died waiting for OLT	15
TACE and liver transplantation	20	0	20
Liver transplantation	7	1	6
Total	84	10	74